Literature DB >> 28107008

Robust, Sensitive, and Automated Phosphopeptide Enrichment Optimized for Low Sample Amounts Applied to Primary Hippocampal Neurons.

Harm Post1,2, Renske Penning1,2, Martin A Fitzpatrick1,2, Luc B Garrigues1,2, W Wu1,2, Harold D MacGillavry3, Casper C Hoogenraad3, Albert J R Heck1,2, A F Maarten Altelaar1,2.   

Abstract

Because of the low stoichiometry of protein phosphorylation, targeted enrichment prior to LC-MS/MS analysis is still essential. The trend in phosphoproteome analysis is shifting toward an increasing number of biological replicates per experiment, ideally starting from very low sample amounts, placing new demands on enrichment protocols to make them less labor-intensive, more sensitive, and less prone to variability. Here we assessed an automated enrichment protocol using Fe(III)-IMAC cartridges on an AssayMAP Bravo platform to meet these demands. The automated Fe(III)-IMAC-based enrichment workflow proved to be more effective when compared to a TiO2-based enrichment using the same platform and a manual Ti(IV)-IMAC-based enrichment workflow. As initial samples, a dilution series of both human HeLa cell and primary rat hippocampal neuron lysates was used, going down to 0.1 μg of peptide starting material. The optimized workflow proved to be efficient, sensitive, and reproducible, identifying, localizing, and quantifying thousands of phosphosites from just micrograms of starting material. To further test the automated workflow in genuine biological applications, we monitored EGF-induced signaling in hippocampal neurons, starting with only 200 000 primary cells, resulting in ∼50 μg of protein material. This revealed a comprehensive phosphoproteome, showing regulation of multiple members of the MAPK pathway and reduced phosphorylation status of two glutamate receptors involved in synaptic plasticity.

Entities:  

Keywords:  BRAVO AssayMap; EGF; Fe(III)-IMAC; Ti(IV)-IMAC; TiO2; hippocampal neurons; phosphopeptide enrichment; phosphoproteomics; quantification; sensitivity

Mesh:

Substances:

Year:  2016        PMID: 28107008     DOI: 10.1021/acs.jproteome.6b00753

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  33 in total

1.  Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction.

Authors:  Nagib Ahsan; Judson Belmont; Zhuo Chen; James G Clifton; Arthur R Salomon
Journal:  J Proteomics       Date:  2017-06-17       Impact factor: 4.044

2.  Targeted Analysis of Lysosomal Directed Proteins and Their Sites of Mannose-6-phosphate Modification.

Authors:  Tomislav Čaval; Jing Zhu; Weihua Tian; Sanne Remmelzwaal; Zhang Yang; Henrik Clausen; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2018-09-20       Impact factor: 5.911

3.  Combined EGFR and ROCK Inhibition in Triple-negative Breast Cancer Leads to Cell Death Via Impaired Autophagic Flux.

Authors:  Stamatia Rontogianni; Sedef Iskit; Sander van Doorn; Daniel S Peeper; Maarten Altelaar
Journal:  Mol Cell Proteomics       Date:  2019-11-26       Impact factor: 5.911

4.  Temporal Quantitative Proteomics of mGluR-induced Protein Translation and Phosphorylation in Neurons.

Authors:  Charlotte A G H van Gelder; Renske Penning; Tim S Veth; Lisa A E Catsburg; Casper C Hoogenraad; Harold D MacGillavry; Maarten Altelaar
Journal:  Mol Cell Proteomics       Date:  2020-09-10       Impact factor: 5.911

5.  Single-Shot Capillary Zone Electrophoresis-Tandem Mass Spectrometry Produces over 4400 Phosphopeptide Identifications from a 220 ng Sample.

Authors:  Zhenbin Zhang; Alexander S Hebert; Michael S Westphall; Joshua J Coon; Norman J Dovichi
Journal:  J Proteome Res       Date:  2019-06-26       Impact factor: 4.466

Review 6.  Recent advances in phosphoproteomics and application to neurological diseases.

Authors:  Justine V Arrington; Chuan-Chih Hsu; Sarah G Elder; W Andy Tao
Journal:  Analyst       Date:  2017-11-20       Impact factor: 4.616

7.  Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington's Disease Mice Prior to Onset of Symptoms.

Authors:  Isaline Mees; Harvey Tran; Anne Roberts; Larissa Lago; Shanshan Li; Blaine R Roberts; Anthony J Hannan; Thibault Renoir
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.590

8.  CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.

Authors:  Souvik Ghosh; Meric Ataman; Maciej Bak; Anastasiya Börsch; Alexander Schmidt; Katarzyna Buczak; Georges Martin; Beatrice Dimitriades; Christina J Herrmann; Alexander Kanitz; Mihaela Zavolan
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

9.  Targeted Quantification of Phosphorylation Dynamics in the Context of EGFR-MAPK Pathway.

Authors:  Lian Yi; Tujin Shi; Marina A Gritsenko; Chi-Yuet X'avia Chan; Thomas L Fillmore; Becky M Hess; Adam C Swensen; Tao Liu; Richard D Smith; H Steven Wiley; Wei-Jun Qian
Journal:  Anal Chem       Date:  2018-04-03       Impact factor: 6.986

10.  Transcriptomic, proteomic and phosphoproteomic underpinnings of daily exercise performance and zeitgeber activity of training in mouse muscle.

Authors:  Geraldine Maier; Julien Delezie; Pål O Westermark; Gesa Santos; Danilo Ritz; Christoph Handschin
Journal:  J Physiol       Date:  2021-07-09       Impact factor: 6.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.